In the realm of the stock market, there have been numerous folks who have come and disappeared within a few years. However, there are a few gems who have stood the test of time and have made a dent in the universe of the stock market.
Shri Ramesh S. Damani, Member Bombay Stock Exchange is one such rare jewel who has been in the markets for over two decades. In a conversation with Soumya Malani, he shared his incredible journey and laid out his investment philosophy.
Where do you think the current bull market stands? What do you suggest should be one’s strategy at this juncture?
There are three phases of the bull market. Phase one is the initial uptake in the markets. Phase two is the longest and perhaps the slowest phase in a bull market. Phase three is almost always a vertical rise in the markets where majority of retail participant jump in and a huge amount of euphoria is witnessed. In phase three it is typical to find the extreme discrepancy between price and value. My sense is that we are in the phase two. Ideal strategy should be to stick to the basics, which is to find and invest in good businesses at a reasonable valuation and hold it. Also one of the crucial lessons that I’ve learnt is never to try and time the market but rather time in the market. Only at rare extremes (too much pessimism or too much optimism) one might be able to time the market, but otherwise it is very difficult and foolhardy to time the market.
Charlie Munger talks about the mental model of Inversion and emphasizes on the significance of avoiding stupidity rather than being intelligent. How vital do you feel it is to first learn to avoid inferior business than focusing on finding great business?
I always tell young analysts or fresh market participants that their job should be to try and double their money every three years. So to find a stock which can double in three years, the first question one must ask is that ‘is this business going to be around three years from now and will it be better off than it is today?’ That question will itself weed out a lot of bad business as you might not have a clue about the sustainability of several businesses. This is a good way to narrow down the pool of business to study. In life also if you know what you don’t want and what to avoid, things become relatively easier.
This story is from the July 2017 edition of Indian Economy & Market.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the July 2017 edition of Indian Economy & Market.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Globalism, Freedom & Democracy Do Not Mix
The world today is packed with wealthy institutions and individuals that stand in revolt against the ideas of freedom and democracy. They do not like the idea of geographically constrained states with zones of juridical power.
WORLD DEVELOPMENT REPORT 2024 THE MIDDLE-INCOME TRAP
A World Bank report titled 'World Development Report 2024: The Middle-Income Trap' indicates that India may take up to 75 years to attain just a quarter of the United States' per capita income. The insights in the report provides a useful reality check for India's ambitious goals, such as becoming a developed economy by 2047 or reaching a $5 trillion economy within the next three years.
IN CONVERSATION: "We are working with a Vision 2035. I'm sure within next 5 years we will be ranking among the Fortune 500 companies.”
Sudarshan Pharma Industries Ltd., led by its promoters, Mr. Hemal V. Mehta, a chemical engineer, and Mr. Sachin V. Mehta, has established a strong foundation in specialty chemicals and bulk drugs. Their relentless enthusiasm is visible when they speak. Indian Economy & Market reached out, to piece together the company's achievements and new initiatives in detail.
Sudarshan Pharma Industries Ltd. A MULTIBAGGER IN MAKING
Sudarshan Pharma Industries Ltd. operates across various sectors in both the pharmaceutical and chemical industries, with a focus on specialty chemicals and intermediates, which find applications in Indian Le pharmaceuticals, paints, food products, and adhesives.
MUTUAL FUND LITE OR MF LIT PROMISING PROGRESS FOR INVESTORS
The SEBI has streamlined rules for passively managed schemes to have the impact of letting more players in the mutual fund ecosystem and offering diversified, low-risk investment options to retail investors. It would increase market liquidity and attract participation from old as well as new Asset Management Companies (AMCs). Shivanand Pandit feels that MF Lite is going to democratize investment opportunities in the Indian financial market.
BRICS Member States Ready to Dethrone Dollar
AS the US weaponises the dollar in the Russian and Iranian sanctions, there is increasing desire by other developing countries to seek alternative currencies for trade, investment, and reserves, as well as developing alternative multilateral clearance systems outside of SWIFT.
7 BEST PHARMA COMPANIES
The pharmaceutical industry in India is expected to reach $65 Bn by end of 2024 and to $130 Bn by 2030. India is a major exporter of Pharmaceuticals, with over 200+ countries served by Indian pharma exports. While Nifty's performance has been lackluster over the past month, several pharmaceutical stocks have shown resilience.
NEW INVESTMENT PRODUCT CATEGORY IS SEBI'S LATEST MOVE COMMENDABLE?
The Securities and Exchange Board of India (SEBI) has introduced a consultation paper proposing a new investment product category aimed at addressing a specific market need. This proposed asset class would offer investment options that sit between mutual funds (MFS) and PMS, filling a gap and providing greater flexibility in portfolio management. The new investment vehicle is designed for investors who are prepared to take on riskier market positions but find PMS schemes or AIFs out of reach. SEBI after reviewing the feedback and finalizing the regulations through stakeholder discussions, may issue the final regulations.
DECODING THE CHINA MYTH
Myths die hard. Among these is the great myth that China's poised to take over the world. Here, James Rickards debunks that myth.
What Is In Store For The Indian Economy?
Until the 2014 Lok Sabha elections, when the Bharatiya Janata Party secured 282 seats and Narendra Modi ascended to power, India experienced 21 years of coalition governments. A decade later, the BJP holds 240 seats in the Lok Sabha, and India is once again governed by a coalition. Fitch has indicated that coalition politics and a weakened mandate for the NDA could hinder the passage of ambitious reform legislation. It raises the question: Do coalition governments impede the economic reform agenda?